Literature DB >> 20514929

Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis.

S Peric'1, V Rakocevic-Stojanovic, Z Stevic, I Basta, S Pavlovic, V Vujanac, L Marjanovic, D Lavrnic.   

Abstract

The aim was to assess factors that might influence health-related quality of life (HRQoL) in patients with two different neuromuscular disorders - myotonic dystrophy type 1 (DM1) and amyotrophic lateral sclerosis (ALS). A cross-sectional study was performed on 79 patients with DM1 and 74 with ALS. The HRQoL was evaluated by SF-36, Serbian version. Depressive and anxiety symptoms were assessed using the Hamilton rating scale for depression and the Hamilton rating scale for anxiety respectively. Severity of muscular involvement in DM1 was measured with MRC scale and severity of ALS with ALSFRSr score. The mean total score as well as all domain scores of SF-36 were similar in DM1 and ALS patients (p > 0.05), except that ALS patients experienced less bodily pain (p < 0.05). Depressiveness was found in 51% and marked anxiety in 38% of DM1 patients. Emotional status and severity of muscular involvement emerged as significant independent contributing factors to the total SF-36 in DMI patients (p < 0.05). Only 3% of ALS patients showed depressiveness and 4% anxiety symptoms. The factors found to contribute to HRQoL in ALS patients were severity of disease and educational level ofpatients (p < 0.05). We found significant percentage of potentially treatable emotional disturbances which together with severity of disease significantly contributed to HRQoL in DM1 patients. On the other hand, in ALS patients depressiveness and anxious symptoms were uncommon and the factors found to contribute to HRQoL were severity of disease and educational level.

Entities:  

Mesh:

Year:  2010        PMID: 20514929

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  8 in total

1.  Pain location and intensity impacts function in persons with myotonic dystrophy type 1 and facioscapulohumeral dystrophy with chronic pain.

Authors:  Jordi Miró; Kevin J Gertz; Gregory T Carter; Mark P Jensen
Journal:  Muscle Nerve       Date:  2014-06       Impact factor: 3.217

2.  Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia).

Authors:  Ivana Z Basta; Tatjana D Pekmezović; Stojan Z Perić; Darija B Kisić-Tepavčević; Vidosava M Rakočević-Stojanović; Zorica D Stević; Dragana V Lavrnić
Journal:  Neurol Sci       Date:  2012-08-09       Impact factor: 3.307

3.  Understanding the experience of myotonic dystrophy. Mixed method study.

Authors:  Amy Østertun Geirdal; Inger Lund-Petersen; Arvid Heiberg
Journal:  J Genet Couns       Date:  2014-08-16       Impact factor: 2.537

Review 4.  Associations between psychological factors and health-related quality of life and global quality of life in patients with ALS: a systematic review.

Authors:  Annerieke C van Groenestijn; Esther T Kruitwagen-van Reenen; Johanna M A Visser-Meily; Leonard H van den Berg; Carin D Schröder
Journal:  Health Qual Life Outcomes       Date:  2016-07-20       Impact factor: 3.186

5.  Personality traits in patients with myotonic dystrophy type 2.

Authors:  Teodora Paunic; Stojan Peric; Aleksandra Parojcic; Dusanka Savic-Pavicevic; Milorad Vujnic; Jovan Pesovic; Ivana Basta; Dragana Lavrnic; Vidosava Rakocevic-Stojanovic
Journal:  Acta Myol       Date:  2017-03

Review 6.  A Review of Psychopathology Features, Personality, and Coping in Myotonic Dystrophy Type 1.

Authors:  Lisa Minier; Baptiste Lignier; Cyrille Bouvet; Benjamin Gallais; Nathalie Camart
Journal:  J Neuromuscul Dis       Date:  2018

7.  Health-Related Quality of Life in Patients with Adult-Onset Myotonic Dystrophy Type 1: A Systematic Review.

Authors:  Erik Landfeldt; Josefin Edström; Cecilia Jimenez-Moreno; Baziel G M van Engelen; Janbernd Kirschner; Hanns Lochmüller
Journal:  Patient       Date:  2019-08       Impact factor: 3.883

8.  Do pain, anxiety and depression influence quality of life for people with amyotrophic lateral sclerosis/motor neuron disease? A national study reconciling previous conflicting literature.

Authors:  Rhiannon Edge; Roger Mills; Alan Tennant; Peter J Diggle; Carolyn A Young
Journal:  J Neurol       Date:  2019-11-07       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.